JP2010538608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010538608A5 JP2010538608A5 JP2010524055A JP2010524055A JP2010538608A5 JP 2010538608 A5 JP2010538608 A5 JP 2010538608A5 JP 2010524055 A JP2010524055 A JP 2010524055A JP 2010524055 A JP2010524055 A JP 2010524055A JP 2010538608 A5 JP2010538608 A5 JP 2010538608A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- binding protein
- chain variable
- sequence
- variable domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97117807P | 2007-09-10 | 2007-09-10 | |
| US60/971,178 | 2007-09-10 | ||
| US9167608P | 2008-08-25 | 2008-08-25 | |
| US61/091,676 | 2008-08-25 | ||
| PCT/US2008/010510 WO2009035577A1 (en) | 2007-09-10 | 2008-09-09 | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014243277A Division JP2015091820A (ja) | 2007-09-10 | 2014-12-01 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010538608A JP2010538608A (ja) | 2010-12-16 |
| JP2010538608A5 true JP2010538608A5 (enExample) | 2011-10-27 |
| JP5956716B2 JP5956716B2 (ja) | 2016-07-27 |
Family
ID=40242598
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010524055A Active JP5956716B2 (ja) | 2007-09-10 | 2008-09-09 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2014243277A Pending JP2015091820A (ja) | 2007-09-10 | 2014-12-01 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2017000937A Pending JP2017110011A (ja) | 2007-09-10 | 2017-01-06 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2018211180A Pending JP2019038843A (ja) | 2007-09-10 | 2018-11-09 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2019227914A Pending JP2020058365A (ja) | 2007-09-10 | 2019-12-18 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2021132141A Pending JP2021191758A (ja) | 2007-09-10 | 2021-08-16 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2023014362A Pending JP2023065375A (ja) | 2007-09-10 | 2023-02-02 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2024111769A Pending JP2024161358A (ja) | 2007-09-10 | 2024-07-11 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014243277A Pending JP2015091820A (ja) | 2007-09-10 | 2014-12-01 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2017000937A Pending JP2017110011A (ja) | 2007-09-10 | 2017-01-06 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2018211180A Pending JP2019038843A (ja) | 2007-09-10 | 2018-11-09 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2019227914A Pending JP2020058365A (ja) | 2007-09-10 | 2019-12-18 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2021132141A Pending JP2021191758A (ja) | 2007-09-10 | 2021-08-16 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2023014362A Pending JP2023065375A (ja) | 2007-09-10 | 2023-02-02 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
| JP2024111769A Pending JP2024161358A (ja) | 2007-09-10 | 2024-07-11 | 胸腺間質性リンパ球性新生因子に結合することができる抗原結合タンパク質 |
Country Status (36)
Families Citing this family (168)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0603683D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
| AR064333A1 (es) | 2006-12-14 | 2009-04-01 | Schering Corp | Anticuerpo anti-tslp de diseno |
| MX2010008096A (es) * | 2008-01-25 | 2010-09-22 | Amgen Inc | Anticuerpos de ferroportina y metodos de uso. |
| MY162511A (en) * | 2009-11-04 | 2017-06-15 | Merck Sharp & Dohme | Engineered anti-tslp antibody |
| WO2012040518A2 (en) * | 2010-09-22 | 2012-03-29 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
| EP2773774A4 (en) * | 2011-11-03 | 2015-06-10 | Merck Sharp & Dohme | BIOMARKERS FOR TSLP TREATMENT |
| KR102292840B1 (ko) * | 2012-04-27 | 2021-08-25 | 노보 노르디스크 에이/에스 | 사람 cd30 리간드 항원 결합 단백질 |
| UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| US9708375B2 (en) | 2013-03-15 | 2017-07-18 | Amgen Inc. | Inhibitory polypeptides specific to WNT inhibitors |
| CN104371019B (zh) * | 2013-08-13 | 2019-09-10 | 鸿运华宁（杭州）生物医药有限公司 | 一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质 |
| TW201605896A (zh) | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
| JP6668241B2 (ja) | 2013-09-05 | 2020-03-18 | アムジエン・インコーポレーテツド | 予測可能で、一貫性のある、且つ再現可能な糖型特性を示すＦｃ含有分子 |
| WO2015118124A1 (en) * | 2014-02-06 | 2015-08-13 | Vib Vzw | Thymic stromal lymphopoietin receptor antagonist |
| EP3139977B1 (en) | 2014-05-07 | 2021-02-17 | Amgen Inc. | Autoinjector with shock reducing elements |
| JP6671298B2 (ja) | 2014-05-16 | 2020-03-25 | アムジェン インコーポレイテッド | Ｔｈ１及びｔｈ２細胞集団を検出するためのアッセイ |
| SG11201609966SA (en) | 2014-06-03 | 2016-12-29 | Amgen Inc | Drug delivery system and method of use |
| WO2016061220A2 (en) | 2014-10-14 | 2016-04-21 | Amgen Inc. | Drug injection device with visual and audio indicators |
| ES2964713T3 (es) | 2014-10-23 | 2024-04-09 | Amgen Inc | Reducción de la viscosidad de formulaciones farmacéuticas |
| WO2016100055A1 (en) | 2014-12-19 | 2016-06-23 | Amgen Inc. | Drug delivery device with live button or user interface field |
| WO2016133947A1 (en) | 2015-02-17 | 2016-08-25 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| JP2018512184A (ja) | 2015-02-27 | 2018-05-17 | アムジエン・インコーポレーテツド | 針ガードの移動に対する抵抗力の閾値が調整可能な針ガード機構を備えた薬物送達装置 |
| AU2016231122A1 (en) * | 2015-03-11 | 2017-09-07 | Glaxosmithkline Intellectual Property Development Limited | TSLP binding proteins |
| WO2016187594A1 (en) * | 2015-05-21 | 2016-11-24 | Harpoon Therapeutics, Inc. | Trispecific binding proteins and methods of use |
| WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
| NZ740067A (en) | 2015-09-09 | 2021-07-30 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules |
| WO2017042701A1 (en) * | 2015-09-09 | 2017-03-16 | Novartis Ag | Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies |
| WO2017100501A1 (en) | 2015-12-09 | 2017-06-15 | Amgen Inc. | Auto-injector with signaling cap |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| JP7252760B2 (ja) | 2016-01-22 | 2023-04-05 | メルク・シャープ・アンド・ドーム・エルエルシー | 抗凝固因子ｘｉ抗体 |
| GB201615588D0 (en) * | 2016-09-14 | 2016-10-26 | Glaxosmithkline Ip Dev Ltd | TSLP Binding Proteins |
| ES3039908T3 (en) | 2016-03-15 | 2025-10-27 | Amgen Inc | Reducing probability of glass breakage in drug delivery devices |
| KR20180132766A (ko) * | 2016-04-05 | 2018-12-12 | 브이아이비 브이지더블유 | 신규한 ｔｓｌｐ 저해인자 |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
| AU2017263558B2 (en) | 2016-05-13 | 2022-12-22 | Amgen Inc. | Vial sleeve assembly |
| US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
| JP7101621B2 (ja) | 2016-05-20 | 2022-07-15 | ハープーン セラピューティクス，インク． | 単一ドメイン血清アルブミン結合タンパク質 |
| US11541176B2 (en) | 2016-06-03 | 2023-01-03 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
| TWI752964B (zh) | 2016-06-14 | 2022-01-21 | 美商默沙東藥廠 | 抗凝血因子ｘｉ抗體 |
| US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
| RU2721582C1 (ru) * | 2016-08-05 | 2020-05-20 | И-Байолоджикс Инк. | Антитела против лиганда-1 запрограммированной смерти (PD-L1) и их применение |
| US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
| EP3532127A1 (en) | 2016-10-25 | 2019-09-04 | Amgen Inc. | On-body injector |
| TWI784988B (zh) | 2016-12-01 | 2022-12-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| AU2018210301A1 (en) | 2017-01-17 | 2019-08-01 | Amgen Inc. | Injection devices and related methods of use and assembly |
| KR20200108915A (ko) | 2017-01-24 | 2020-09-21 | 아이-맵 바이오파마 유에스 리미티드 | 항-cd73 항체 및 이것의 사용 |
| EP3582829A1 (en) | 2017-02-17 | 2019-12-25 | Amgen Inc. | Insertion mechanism for drug delivery device |
| MX2019009625A (es) | 2017-02-17 | 2019-10-09 | Amgen Inc | Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje. |
| JP7377596B2 (ja) | 2017-02-22 | 2023-11-10 | アムジエン・インコーポレーテツド | 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法 |
| ES3051784T3 (en) | 2017-03-06 | 2025-12-30 | Amgen Inc | Drug delivery device with activation prevention feature |
| US11571511B2 (en) | 2017-03-07 | 2023-02-07 | Amgen Inc. | Insertion mechanism and method of inserting a needle of a drug delivery device |
| WO2018165499A1 (en) | 2017-03-09 | 2018-09-13 | Amgen Inc. | Insertion mechanism for drug delivery device |
| US12503700B2 (en) | 2017-03-14 | 2025-12-23 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| LT3600491T (lt) | 2017-03-28 | 2023-10-10 | Amgen Inc. | Stūmoklio koto ir švirkšto konstrukcinė sistema ir būdas |
| JOP20190243A1 (ar) | 2017-04-12 | 2019-10-13 | Medimmune Llc | علاج الربو بجسم مضاد لـ tslp |
| AU2018258676B2 (en) | 2017-04-28 | 2024-09-19 | Amgen Inc. | N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides |
| CA3066399A1 (en) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Torque driven drug delivery device |
| US11590294B2 (en) | 2017-06-08 | 2023-02-28 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
| JP7195276B2 (ja) | 2017-06-22 | 2022-12-23 | アムジエン・インコーポレーテツド | デバイス起動による衝突／衝撃の低減 |
| JP7475860B2 (ja) | 2017-06-23 | 2024-04-30 | アムジエン・インコーポレーテツド | スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス |
| CN109206514B (zh) * | 2017-07-03 | 2019-10-08 | 拜西欧斯（北京）生物技术有限公司 | Tslp单克隆抗体及其制备方法和应用 |
| WO2019014014A1 (en) | 2017-07-14 | 2019-01-17 | Amgen Inc. | NEEDLE INSERTION-RETRACTING SYSTEM HAVING DOUBLE TORSION SPRING SYSTEM |
| EP3655063A1 (en) | 2017-07-21 | 2020-05-27 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
| US11617837B2 (en) | 2017-07-25 | 2023-04-04 | Amgen Inc. | Drug delivery device with gear module and related method of assembly |
| WO2019022950A1 (en) | 2017-07-25 | 2019-01-31 | Amgen Inc. | DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF |
| EA202090380A1 (ru) | 2017-08-01 | 2020-05-21 | Эмджен Инк. | Системы и способы для выполнения анализа гликанов в образце в режиме реального времени |
| WO2019028187A1 (en) | 2017-08-01 | 2019-02-07 | Amgen Inc. | SYSTEMS AND METHODS FOR REAL-TIME PREPARATION OF A POLYPEPTIDE SAMPLE FOR MASS SPECTROMETRY ANALYSIS |
| EP3664863A2 (en) | 2017-08-09 | 2020-06-17 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
| EA202090427A1 (ru) | 2017-08-16 | 2020-06-08 | МЕДИММЬЮН, ЭлЭлСи | Композиции и способы лечения атопического дерматита и выбора лечения |
| MA49897A (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| US11759565B2 (en) | 2017-10-04 | 2023-09-19 | Amgen Inc. | Flow adapter for drug delivery device |
| EP4257164A3 (en) | 2017-10-06 | 2024-01-17 | Amgen Inc. | Drug delivery device with interlock assembly and related method of assembly |
| EP3694578B1 (en) | 2017-10-09 | 2025-09-24 | Amgen Inc. | Drug delivery device with drive assembly and related method of assembly |
| IL315737A (en) | 2017-10-13 | 2024-11-01 | Harpoon Therapeutics Inc | B-cell maturation antigen-binding proteins |
| PE20201183A1 (es) | 2017-10-13 | 2020-11-03 | Harpoon Therapeutics Inc | Proteinas trispecificas y metodos de uso |
| EP3703778A1 (en) | 2017-11-03 | 2020-09-09 | Amgen Inc. | System and approaches for sterilizing a drug delivery device |
| MA50553A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Dispositif d'administration de médicament avec détection de positionnement et de débit |
| MA50569A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Ensembles de remplissage-finition et procédés associés |
| EP3706826A1 (en) | 2017-11-10 | 2020-09-16 | Amgen Inc. | Plungers for drug delivery devices |
| AU2018368340B2 (en) | 2017-11-16 | 2024-03-07 | Amgen Inc. | Door latch mechanism for drug delivery device |
| ES3042632T3 (en) | 2018-03-13 | 2025-11-24 | Amgen Inc | Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis |
| EP3765857B1 (en) | 2018-03-13 | 2025-12-10 | Amgen Inc. | Sequential digestion of polypeptides for mass spectrometric analysis |
| JP2021519068A (ja) | 2018-03-26 | 2021-08-10 | アムジェン インコーポレイテッド | 細胞培養において産生される抗体の総非フコシル化グリコフォーム |
| KR20210020903A (ko) | 2018-05-14 | 2021-02-24 | 하푼 테라퓨틱스, 인크. | 면역글로불린 분자의 조건부 활성화를 위한 결합 모이어티 |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| EP3826701A1 (en) | 2018-07-24 | 2021-06-02 | Amgen Inc. | Delivery devices for administering drugs |
| US12303677B2 (en) | 2018-07-24 | 2025-05-20 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
| WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
| CA3103682A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
| WO2020028009A1 (en) | 2018-07-31 | 2020-02-06 | Amgen Inc. | Fluid path assembly for a drug delivery device |
| WO2020061482A1 (en) | 2018-09-21 | 2020-03-26 | Harpoon Therapeutics, Inc. | Egfr binding proteins and methods of use |
| US20210346601A1 (en) | 2018-09-24 | 2021-11-11 | Amgen Inc. | Interventional dosing systems and methods |
| CA3114038A1 (en) | 2018-09-25 | 2020-04-02 | Harpoon Therapeutics, Inc. | Dll3 binding proteins and methods of use |
| MA53718A (fr) | 2018-09-28 | 2022-01-05 | Amgen Inc | Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament |
| MX2021003492A (es) | 2018-10-02 | 2021-06-18 | Amgen Inc | Sistemas de inyeccion para la administracion de farmacos con transmision de fuerza interna. |
| TW202529830A (zh) | 2018-10-05 | 2025-08-01 | 美商安進公司 | 具有劑量指示器之藥物遞送裝置 |
| KR20250127186A (ko) | 2018-10-15 | 2025-08-26 | 암젠 인크 | 댐핑 메커니즘을 갖는 약물 전달 장치 |
| SG11202101824VA (en) | 2018-10-15 | 2021-03-30 | Amgen Inc | Platform assembly process for drug delivery device |
| AU2019370159B2 (en) | 2018-11-01 | 2025-05-29 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| WO2020091956A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
| JP7769544B2 (ja) | 2018-12-14 | 2025-11-13 | アムジエン・インコーポレーテツド | 勾配によるタンパク質濃度定量を伴う使用のためのシステム適合性方法 |
| WO2020142693A1 (en) * | 2019-01-04 | 2020-07-09 | Empirico Inc. | Treatment of thymic stromal lymphopoietin (tslp) related diseases by inhibition of long-form tslp transcripts |
| EP4397977A3 (en) | 2019-02-14 | 2024-09-11 | Amgen Inc. | Systems and methods for preparing a sample and performing a real-time assay of the sample |
| CA3127817A1 (en) | 2019-02-20 | 2020-08-27 | Amgen Inc. | Methods of determining protein stability |
| MX2021010414A (es) | 2019-03-04 | 2021-09-14 | Amgen Inc | Reversibilidad in vivo de especies de alto peso molecular. |
| AU2020245573B2 (en) | 2019-03-27 | 2025-11-20 | Amgen Inc. | Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products |
| WO2020219482A1 (en) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
| MX2021014804A (es) | 2019-06-04 | 2022-01-18 | Jiangsu Hengrui Medicine Co | Anticuerpo capaz de unirse a la linfopoyetina estromal timica y el uso del mismo. |
| AU2020288652A1 (en) | 2019-06-05 | 2021-11-18 | Amgen Inc. | Methods of identifying attributes of therapeutic proteins |
| US12435131B2 (en) | 2019-07-11 | 2025-10-07 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling |
| MX2022002149A (es) | 2019-08-23 | 2022-03-17 | Amgen Inc | Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados. |
| AU2020355251A1 (en) | 2019-09-26 | 2022-04-21 | Amgen Inc. | Methods of producing antibody compositions |
| MX2022005083A (es) * | 2019-10-28 | 2022-07-19 | Medimmune Ltd | Formulaciones en polvo seco de anticuerpos de unión a linfopoyetina estromal tímica (tslp) y métodos para usarlos. |
| CN112876564B (zh) * | 2019-11-29 | 2022-07-15 | 康诺亚生物医药科技（成都）有限公司 | 一种tslp相关病症治疗剂的开发和应用 |
| MX2022004919A (es) * | 2019-12-13 | 2022-05-16 | Sichuan Kelun Biotech Biopharmaceutical Co Ltd | Anticuerpo anti-linfopoyetina estromal timica (tslp) y sus usos. |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| CN111171150B (zh) * | 2020-02-05 | 2020-12-08 | 北京智仁美博生物科技有限公司 | 抗人tslp抗体及其用途 |
| WO2021163588A1 (en) | 2020-02-13 | 2021-08-19 | Amgen Inc. | Treatment of atopic dermatitis with anti-tslp antibody |
| IL295042A (en) | 2020-02-13 | 2022-09-01 | Amgen Inc | Formulations of human anti-tslp antibodies and methods of treating inflammatory disease |
| WO2021168100A1 (en) | 2020-02-18 | 2021-08-26 | Amgen Inc. | Formulations of human anti-tslp antibodies and methods of using the same |
| CN111662379B (zh) * | 2020-05-09 | 2021-03-02 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 抗新型冠状病毒的抗体、制备方法和应用 |
| KR20230024904A (ko) * | 2020-05-20 | 2023-02-21 | 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 | Sars-cov-2에 대한 강력한 중화 항체, 그의 생성 및 용도 |
| US20230273126A1 (en) | 2020-06-04 | 2023-08-31 | Amgen Inc. | Assessment of cleaning procedures of a biotherapeutic manufacturing process |
| EP4214226A1 (en) | 2020-09-18 | 2023-07-26 | Amgen Inc. | Methods of processing a sample for peptide mapping analysis |
| US20240043501A1 (en) | 2020-10-15 | 2024-02-08 | Amgen Inc. | Relative unpaired glycans in antibody production methods |
| US20240010672A1 (en) | 2020-11-05 | 2024-01-11 | Amgen Inc. | Materials and methods for protein processing |
| CN114437212B (zh) * | 2020-11-06 | 2023-03-14 | 上海麦济生物技术有限公司 | 抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用 |
| WO2022117079A1 (zh) * | 2020-12-03 | 2022-06-09 | 江苏恒瑞医药股份有限公司 | 结合胸腺基质淋巴细胞生成素的抗体及其应用 |
| CN113501878B (zh) | 2021-02-03 | 2022-12-02 | 北京智仁美博生物科技有限公司 | 针对人tslp的多种抗体及其用途 |
| EP4288454A4 (en) * | 2021-02-04 | 2025-06-25 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing thymic stromal lymphopoietin and uses thereof |
| EP4326766A1 (en) | 2021-04-23 | 2024-02-28 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
| TW202304980A (zh) | 2021-04-23 | 2023-02-01 | 美商安進公司 | 經修飾的抗ｔｓｌｐ抗體 |
| WO2022246055A1 (en) | 2021-05-21 | 2022-11-24 | Amgen Inc. | Method of optimizing a filling recipe for a drug container |
| AU2022285961A1 (en) * | 2021-05-30 | 2023-12-14 | Biolojic Design Ltd. | Engineered dual binding antibodies and uses thereof |
| AR126089A1 (es) | 2021-06-07 | 2023-09-13 | Amgen Inc | Uso de fucosidasa para controlar el nivel de afucosilación de proteínas glucosiladas |
| CN113069543B (zh) * | 2021-06-07 | 2021-08-06 | 迈威(上海)生物科技股份有限公司 | 包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物 |
| CN113683694B (zh) | 2021-09-03 | 2022-05-13 | 江苏荃信生物医药股份有限公司 | 一种抗人tslp单克隆抗体及其应用 |
| CA3233279A1 (en) | 2021-10-05 | 2023-04-13 | Amgen Inc. | Fc-gamma receptor ii binding and glycan content |
| WO2023070948A1 (zh) * | 2021-11-01 | 2023-05-04 | 江苏荃信生物医药股份有限公司 | 包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂 |
| AU2022388727A1 (en) | 2021-11-09 | 2024-05-16 | Amgen Inc. | Production of therapeutic proteins |
| CN117209603B (zh) * | 2021-12-02 | 2024-02-27 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
| CN114369654B (zh) * | 2021-12-21 | 2023-11-07 | 广州市妇女儿童医疗中心 | 川崎病的生物标志物及其应用 |
| WO2023116925A1 (en) * | 2021-12-24 | 2023-06-29 | Inmagene Biopharmaceuticals (Hangzhou) Co., Ltd. | Novel anti-tslp antibodies |
| IL315262A (en) * | 2022-03-03 | 2024-10-01 | Pfizer | Multiple specific antibodies related to IL-4, IL-13 and/or TSLP and their uses |
| WO2023215725A1 (en) | 2022-05-02 | 2023-11-09 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| US12110324B2 (en) * | 2022-07-22 | 2024-10-08 | Flagship Pioneering Innovations Vi, Llc | Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP) |
| CN118772267B (zh) * | 2022-10-21 | 2025-05-13 | 珠海泰诺麦博制药股份有限公司 | 抗人巨细胞病毒抗体及其用途 |
| AR130862A1 (es) | 2022-10-26 | 2025-01-29 | Amgen Inc | Composiciones de anticuerpos anti-tslp y usos de las mismas |
| TW202448501A (zh) | 2023-02-02 | 2024-12-16 | 美商麥迪紐有限責任公司 | 用抗ｔｓｌｐ抗體治療慢性鼻竇炎 |
| CN120659807A (zh) * | 2023-02-23 | 2025-09-16 | 四川科伦博泰生物医药股份有限公司 | 一种靶向tslp的单克隆抗体制剂 |
| WO2024220916A1 (en) | 2023-04-20 | 2024-10-24 | Amgen Inc. | Methods of determining relative unpaired glycan content |
| CN121443636A (zh) | 2023-05-18 | 2026-01-30 | 免疫医疗有限责任公司 | 用抗tslp抗体治疗皮质类固醇依赖性哮喘 |
| CN121311767A (zh) | 2023-06-14 | 2026-01-09 | 百时美施贵宝公司 | 糖蛋白的近实时唾液酸定量 |
| WO2024264002A2 (en) * | 2023-06-22 | 2024-12-26 | Paragon Therapeutics, Inc. | Antibodies that bind tslp and tslpr and methods of use |
| WO2024264003A2 (en) * | 2023-06-22 | 2024-12-26 | Paragon Therapeutics, Inc. | Antibodies that bind interleukin 13 and tslp or tslpr and methods of use |
| WO2025038600A1 (en) | 2023-08-14 | 2025-02-20 | Amgen Inc. | Methods for reducing yellow color |
| TW202525846A (zh) | 2023-08-25 | 2025-07-01 | 美商普羅特歐拉吉克適美國公司 | 抗ｉｌ—１３多特異性抗體構築體及其用途 |
| AR134102A1 (es) * | 2023-10-12 | 2025-12-03 | Innovent Biologics Suzhou Co Ltd | ANTICUERPOS ANTI-IL-4Ra Y USOS DE LOS MISMOS |
| WO2025101602A1 (en) | 2023-11-07 | 2025-05-15 | Amgen Inc. | Methods of analyzing amino acid content of a therapeutic protein |
| WO2025101820A1 (en) | 2023-11-08 | 2025-05-15 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| WO2025147632A1 (en) | 2024-01-05 | 2025-07-10 | Medimmune, Llc | Treatment of chronic obstructive pulmonary disease with anti-tslp antibody |
| WO2025221247A1 (en) | 2024-04-17 | 2025-10-23 | Amgen Inc. | Treatment of eosinophilic esophagitis with anti-tslp antibody |
| WO2025255028A1 (en) | 2024-06-03 | 2025-12-11 | Amgen Inc. | High-throughput liquid chromatography-mass spectrometry-based peptide mapping |
| WO2025264860A2 (en) | 2024-06-18 | 2025-12-26 | Yale University | Methods of treating post-covid airway disease |
| WO2025265071A1 (en) * | 2024-06-21 | 2025-12-26 | Paragon Therapeutics, Inc. | Antibodies that bind tslp and methods of use |
Family Cites Families (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4411993A (en) | 1981-04-29 | 1983-10-25 | Steven Gillis | Hybridoma antibody which inhibits interleukin 2 activity |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| USRE32011E (en) | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
| JPS58117537A (ja) | 1982-01-06 | 1983-07-13 | Toray Ind Inc | 感光性樹脂組成物 |
| EP0088046B1 (de) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4543439A (en) | 1982-12-13 | 1985-09-24 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3474511D1 (en) | 1983-11-01 | 1988-11-17 | Terumo Corp | Pharmaceutical composition containing urokinase |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| US4902614A (en) | 1984-12-03 | 1990-02-20 | Teijin Limited | Monoclonal antibody to human protein C |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| FI915911A7 (fi) | 1989-06-15 | 1991-12-16 | Immunex Corp | Interleukiini-7-reseptoreja |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| DK0710719T3 (da) | 1990-01-12 | 2007-07-09 | Amgen Fremont Inc | Frembringelse af xenogene antistoffer |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| EP0542810A1 (en) | 1990-08-02 | 1993-05-26 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
| US5877397A (en) | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| DE69127627T2 (de) | 1990-08-29 | 1998-02-19 | Genpharm Int | Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| WO1992022653A1 (en) | 1991-06-14 | 1992-12-23 | Genentech, Inc. | Method for making humanized antibodies |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5262522A (en) | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
| JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化ｂ−ｂ１０ |
| US5869619A (en) | 1991-12-13 | 1999-02-09 | Xoma Corporation | Modified antibody variable domains |
| WO1993021946A1 (en) | 1992-04-30 | 1993-11-11 | Synergen, Inc. | Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| ES2198414T3 (es) | 1992-10-23 | 2004-02-01 | Immunex Corporation | Procedimientos para preparar proteinas oligomericas solubles. |
| EP0737071A1 (en) | 1993-06-15 | 1996-10-16 | Il- Yang Pharm. Co., Ltd. | Anti-sense oligodeoxynucleotide to fibrogenic cytokines and use thereof |
| US5457035A (en) | 1993-07-23 | 1995-10-10 | Immunex Corporation | Cytokine which is a ligand for OX40 |
| US6613544B1 (en) | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| GB9702944D0 (en) | 1997-02-13 | 1997-04-02 | Univ Manchester | Reducing fibrosis |
| US6133426A (en) | 1997-02-21 | 2000-10-17 | Genentech, Inc. | Humanized anti-IL-8 monoclonal antibodies |
| EP0985039B1 (en) | 1997-06-12 | 2008-02-20 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| US6982320B2 (en) | 1998-03-19 | 2006-01-03 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
| ATE490980T1 (de) | 1998-03-19 | 2010-12-15 | Human Genome Sciences | Der gemeinsamen gamma-kette ähnlicher zytokinrezeptor |
| US6844170B1 (en) | 1998-03-19 | 2005-01-18 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
| US6210924B1 (en) | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
| US20030099947A1 (en) | 1998-09-21 | 2003-05-29 | Bazan J. Fernando | Mammalian cytokines; related reagents and methods |
| EP1115867A1 (en) | 1998-09-21 | 2001-07-18 | Schering Corporation | Human interleukin-b50. therapeutic uses |
| CA2349762C (en) | 1998-11-13 | 2013-12-24 | Immunex Corporation | Human tslp dna and polypeptides |
| AU2396600A (en) | 1998-12-30 | 2000-07-31 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| US20010021380A1 (en) | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| GB9928787D0 (en) | 1999-12-03 | 2000-02-02 | Medical Res Council | Direct screening method |
| EP1712239A3 (en) | 2000-05-12 | 2007-08-22 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
| US6955895B2 (en) | 2000-06-28 | 2005-10-18 | Whitehead Institute For Biomedical Research | Thymic stromal lymphopoietin receptor molecules and uses thereof |
| MXPA02012747A (es) | 2000-06-28 | 2003-09-25 | Amgen Inc | Moleculas del receptor de linfopoietina estromica timica y sus usos. |
| GB0025144D0 (en) | 2000-10-13 | 2000-11-29 | Medical Res Council | Concatenated nucleic acid sequences |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| CN1234728C (zh) * | 2001-05-16 | 2006-01-04 | 上海睿星基因技术有限公司 | 新的人淋巴因子、其编码序列及用途 |
| CN1671416B (zh) | 2001-07-12 | 2013-01-02 | 杰斐逊·富特 | 超人源化抗体 |
| PT1417231E (pt) | 2001-07-23 | 2013-07-29 | Immunex Corp | Linfopoietina estromal tímica humana modificada |
| US20030186875A1 (en) | 2002-02-01 | 2003-10-02 | Rene De Waal Malefyt | Uses of mammalian cytokine; related reagents |
| HRP20020453A2 (en) | 2002-05-23 | 2003-12-31 | Pliva D D | 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof |
| DK2213685T3 (en) | 2002-09-06 | 2014-03-03 | Medarex Llc | Therapeutic anti-IL-1R1 monoclonal antibody |
| US20040202995A1 (en) | 2003-04-09 | 2004-10-14 | Domantis | Nucleic acids, proteins, and screening methods |
| NZ544456A (en) | 2003-07-18 | 2009-02-28 | Schering Corp | Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| MEP31408A (en) | 2003-07-18 | 2010-10-10 | Abgenix Inc | Specific binding agents to hepatocyte growth factor |
| ES2384569T3 (es) | 2003-12-19 | 2012-07-09 | Genentech, Inc. | Fragmentos de anticuerpos monovalentes útiles como agentes terapéuticos |
| US20050249712A1 (en) | 2004-03-23 | 2005-11-10 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for use of TSLP and agonists and antagonists thereof |
| AU2005277236A1 (en) | 2004-08-20 | 2006-03-02 | Amgen Inc. | Methods and compositions for treating allergic inflammation |
| ATE492563T1 (de) * | 2004-11-17 | 2011-01-15 | Amgen Inc | Vollständige humane monoklonale antikörper gegen il-13 |
| CN101217979A (zh) | 2005-06-14 | 2008-07-09 | 安姆根有限公司 | 自缓冲蛋白制剂 |
| WO2007112146A2 (en) | 2006-01-13 | 2007-10-04 | Irm Llc | Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
| GB0603683D0 (en) | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
| AR064333A1 (es) | 2006-12-14 | 2009-04-01 | Schering Corp | Anticuerpo anti-tslp de diseno |
| EP2170957A1 (en) | 2007-06-20 | 2010-04-07 | Irm, Llc | Methods and compositions for treating allergic diseases |
| JP5782185B2 (ja) | 2012-06-01 | 2015-09-24 | 日本電信電話株式会社 | パケット転送処理方法およびパケット転送処理装置 |
| US9300829B2 (en) | 2014-04-04 | 2016-03-29 | Canon Kabushiki Kaisha | Image reading apparatus and correction method thereof |
-
2008
- 2008-09-08 US US12/231,944 patent/US7982016B2/en active Active
- 2008-09-09 PH PH1/2017/501025A patent/PH12017501025B1/en unknown
- 2008-09-09 NZ NZ583933A patent/NZ583933A/en unknown
- 2008-09-09 JP JP2010524055A patent/JP5956716B2/ja active Active
- 2008-09-09 KR KR20147029417A patent/KR20140141666A/ko not_active Ceased
- 2008-09-09 PT PT88303623T patent/PT2205635T/pt unknown
- 2008-09-09 TW TW097134513A patent/TWI449709B/zh active
- 2008-09-09 KR KR1020107007193A patent/KR101597371B1/ko active Active
- 2008-09-09 MX MX2010002590A patent/MX2010002590A/es active IP Right Grant
- 2008-09-09 EA EA201590631A patent/EA201590631A1/ru unknown
- 2008-09-09 SI SI200831642A patent/SI2205635T1/sl unknown
- 2008-09-09 EP EP13178927.3A patent/EP2703414A1/en not_active Ceased
- 2008-09-09 TW TW102140859A patent/TW201412774A/zh unknown
- 2008-09-09 CN CN201410253054.9A patent/CN104231081B/zh active Active
- 2008-09-09 EA EA201000471A patent/EA022796B1/ru not_active IP Right Cessation
- 2008-09-09 EP EP19152495.8A patent/EP3524622A1/en active Pending
- 2008-09-09 RS RS20160490A patent/RS54950B1/sr unknown
- 2008-09-09 JO JOP/2008/0401A patent/JO3351B1/ar active
- 2008-09-09 EP EP08830362.3A patent/EP2205635B1/en active Active
- 2008-09-09 ES ES08830362.3T patent/ES2581229T3/es active Active
- 2008-09-09 LT LTEP08830362.3T patent/LT2205635T/lt unknown
- 2008-09-09 MY MYPI2010000985A patent/MY150242A/en unknown
- 2008-09-09 CN CN200880106436.1A patent/CN101809035B/zh active Active
- 2008-09-09 HR HRP20160638TT patent/HRP20160638T1/hr unknown
- 2008-09-09 SG SG10201506251YA patent/SG10201506251YA/en unknown
- 2008-09-09 HU HUE08830362A patent/HUE028361T2/en unknown
- 2008-09-09 CA CA2698382A patent/CA2698382C/en active Active
- 2008-09-09 PL PL08830362.3T patent/PL2205635T3/pl unknown
- 2008-09-09 AU AU2008300028A patent/AU2008300028B2/en active Active
- 2008-09-09 WO PCT/US2008/010510 patent/WO2009035577A1/en not_active Ceased
- 2008-09-09 SG SG2012009817A patent/SG178781A1/en unknown
- 2008-09-09 DK DK08830362.3T patent/DK2205635T3/en active
- 2008-09-09 CL CL2008002668A patent/CL2008002668A1/es unknown
- 2008-09-10 AR ARP080103923A patent/AR068508A1/es active IP Right Grant
- 2008-09-17 PE PE2008001578A patent/PE20110668A1/es not_active Application Discontinuation
- 2008-09-17 PE PE2013001432A patent/PE20140232A1/es active IP Right Grant
-
2010
- 2010-02-21 IL IL204069A patent/IL204069A/en active IP Right Grant
- 2010-03-17 CR CR11319A patent/CR11319A/es unknown
- 2010-03-17 ZA ZA2010/01895A patent/ZA201001895B/en unknown
-
2011
- 2011-07-18 US US13/185,021 patent/US8163284B2/en active Active
-
2012
- 2012-04-03 US US13/438,739 patent/US9284372B2/en active Active
- 2012-11-21 CL CL2012003245A patent/CL2012003245A1/es unknown
-
2014
- 2014-12-01 JP JP2014243277A patent/JP2015091820A/ja active Pending
-
2015
- 2015-02-24 CR CR20150095A patent/CR20150095A/es unknown
-
2016
- 2016-02-03 US US15/014,828 patent/US10287348B2/en active Active
- 2016-06-29 CY CY20161100597T patent/CY1117702T1/el unknown
-
2017
- 2017-01-06 JP JP2017000937A patent/JP2017110011A/ja active Pending
- 2017-03-02 IL IL250900A patent/IL250900A0/en unknown
-
2018
- 2018-11-09 JP JP2018211180A patent/JP2019038843A/ja active Pending
-
2019
- 2019-04-04 IL IL265854A patent/IL265854A/en unknown
- 2019-05-08 US US16/406,811 patent/US20200071393A1/en not_active Abandoned
- 2019-12-18 JP JP2019227914A patent/JP2020058365A/ja active Pending
-
2021
- 2021-08-16 JP JP2021132141A patent/JP2021191758A/ja active Pending
-
2022
- 2022-12-09 CY CY2022036C patent/CY2022036I2/el unknown
- 2022-12-09 NO NO2022055C patent/NO2022055I1/no unknown
- 2022-12-09 LU LU00289C patent/LUC00289I2/fr unknown
- 2022-12-12 FR FR22C1059C patent/FR22C1059I2/fr active Active
- 2022-12-12 LT LTPA2022016C patent/LTC2205635I2/lt unknown
- 2022-12-12 HU HUS2200051C patent/HUS2200051I1/hu unknown
- 2022-12-12 NL NL301207C patent/NL301207I2/nl unknown
-
2023
- 2023-02-02 JP JP2023014362A patent/JP2023065375A/ja active Pending
-
2024
- 2024-07-11 JP JP2024111769A patent/JP2024161358A/ja active Pending
-
2025
- 2025-01-15 US US19/022,014 patent/US20250154241A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010538608A5 (enExample) | ||
| JP2025016349A5 (enExample) | ||
| JP7001474B2 (ja) | 非免疫原性単一ドメイン抗体 | |
| JP2012525829A5 (enExample) | ||
| JP2018516853A5 (enExample) | ||
| CN114746440B (zh) | 新型多肽复合物 | |
| JP2020508655A5 (enExample) | ||
| JP2013507115A5 (enExample) | ||
| JP2010246565A5 (enExample) | ||
| HRP20160638T1 (hr) | Antigen vezujući proteini sposobni vezati timusni stromalni limfopoetin | |
| JP2017052784A5 (enExample) | ||
| JP2012500020A5 (enExample) | ||
| RU2013115927A (ru) | АНТИТЕЛА ПРОТИВ ИЛ-1β И СПОСОБЫ ПРИМЕНЕНИЯ | |
| JP2013523184A5 (enExample) | ||
| JP2018519364A5 (enExample) | ||
| JP2017149720A5 (enExample) | ||
| JP2013538057A5 (enExample) | ||
| JP2016512521A5 (enExample) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| JP2018510617A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2010523592A5 (enExample) | ||
| JPWO2020114480A5 (enExample) | ||
| JP2012530487A5 (enExample) | ||
| RU2016136639A (ru) | Антитела против эотаксина 2, которые распознают дополнительные связывающие CCR3 хемокины |